A benchmark dose analysis for sodium monofluoroacetate (1080) using dichotomous toxicity data

Regulatory Toxicology and Pharmacology

Volumn 47, Issue 1, 2007, Pages 84-89

  Foronda, Natalia M ^a   Fowles, Jefferson ^b   Smith, Nerida ^c   Taylor, Michael ^a   Temple, Wayne ^d  

^a MINISTRY OF HEALTH   (New Zealand)

^b INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^c GRIFFITH UNIVERSITY   (Australia)

^d National Poisons Centre   (New Zealand)

Author keywords

1080; Benchmark dose; Cardiomyopathy; NOAEL; TDI; Teratogen; Testicular

Indexed keywords

FLUOROACETATE SODIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE CALCULATION; LETHAL DOSE; MAXIMUM ALLOWABLE CONCENTRATION; MAXIMUM TOLERATED DOSE; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RAT; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; STATISTICAL ANALYSIS; TERATOGENICITY; TESTIS DISEASE; TOXICITY TESTING;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; BENCHMARKING; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDPOINT DETERMINATION; FEMALE; FLUOROACETATES; HEART DISEASES; HUMANS; MALE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RODENTICIDES; TESTIS; TOXICITY TESTS;

EID: 33751089861     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2006.08.002     Document Type: Article

References (21)

1. Barnes D.G., Daston G.P., Evans J.S., Jarabek A.M., Kavlock R.J., Kimmel C.A., Park C., and Spitzer H.L. Benchmark dose workshop: criteria for use of a benchmark dose to estimate a reference dose. Regul. Toxicol. Pharm. 21 (1995) 296-306
2. Crump K.S. A new method for determining allowable daily intakes. Fund. Appl. Toxicol. 4 (1984) 854-871
3. Crump K.S. Calculation of benchmark doses from continuous data. Risk Anal. 15 1 (1995) 79-89
4. Eason C.T., Wickstrom M., Turck P., and Wright G.R.G. A review of recent regulatory and environmental toxicology studies on 1080: results and implications. N.Z. J. Ecol. 23 2 (1999) 129-137
5. Eason C.T., and Turck P. A 90-day toxicological evaluation of compound 1080 (sodium monofluoroacetate) in Sprague-Dawley Rats. Toxicol. Sci. 69 (2002) 439-447
6. Fowles J.R., Alexeef G.V., and Dodge D. The use of benchmark dose methodology with acute inhalation lethality data. Regul. Toxicol. Pharm. 29 (1999) 262-278
7. Gaylor D.W. Incidence of developmental defects at the no observed adverse effect level (NOAEL). Regul. Toxicol. Pharm. 15 (1992) 151-160
8. Gaylor D. Quantalization of continuous data for benchmark dose estimation. Regul. Toxicol. Pharm. 24 (1996) 246-250
9. Gaylor D.W., Ryan L., Krewski D., and Zhu Y. Procedures for calculating benchmark doses for health risk assessment. Regul. Toxicol. Pharm. 28 (1998) 150-164
10. Gephart L.A., Salminen W.F., Nicolich M.J., and Pelekis M. Evaluation of subchronic toxicity data using benchmark dose approach. Regul. Toxicol. Pharm. 33 1 (2001) 37-59
11. International Programme on Chemical Safety (IPCS). (1994). Environmental Health Criteria 170: Assessing human health risks of chemicals: Derivation of guidance values for health-based exposure limits. Geneva, World Health Organization, International Programme on Chemical Safety.
12. Leisenring W., and Ryan L. Statistical properties of the NOAEL. Regul. Toxicol. Pharm. 15 (1992) 161-171
13. Parfitt, R.I., Eason, C.T., Morgan, A.J., Burke, C.M., Wright, G.R.G. 1994. The fate of sodium monofluoroacetate (1080) in soil and water. In: Seawright, A.A.; Eason, C.T. eds. Proceedings of the Science Workshop on 1080. Royal Society of New Zealand miscellaneous series 28, 59-66.
14. Parliamentary Commissioner for the Environment (PCE). 1994. Possum Management in New Zealand. Office of the Parliamentary Commissioner for the Environment, Wellington.
15. Renwick A.G., and Walker R. An analysis of the risk of exceeding acceptable or tolerable daily intake. Regul. Toxicol. Pharm. 18 (1993) 463-480
16. Sand S., Filiposson A.F., and Victorin K. Evaluation of the benchmark dose method for dichotomous data: model dependence and model selection. Regul. Toxicol. Pharm. 36 2 (2002) 184-197
17. Sullivan J.L., Smith F.A., and Garman R.H. Effects of fluoroacetate on the testis of the rat. J. Reprod. Fertil. 56 (1979) 201-207
18. U.S. Environmental Protection Agency (US EPA). 1995. The use of the benchmark dose approach in health risk assessment. Office of Research and Development, Washington, DC: EPA/630/R-94/007, February.
19. US. Environmental Protection Agency (US EPA). 2001. Benchmark dose software. U.S. Environmental Protection Agency.
20. US. Environmental Protection Agency (US EPA). 2003. Benchmark dose tutorial. U.S. Environmental Protection Agency. .
21. Whittem J.H., and Murray L.R. The chemistry and pathology of georgina river poisoning. Australian Vet. J. 39 (1963) 168-173